“…Palmarumycins CP 17 , B 6 , and C 8 (Figure ) were isolated from the endophytic fungus Berkleasmium sp., which was purified from the medicinal plant Dioscorea zingiberensis C. H. Wright. These compounds exhibited excellent larvicidal activity against the mosquito A. albopictus and antibacterial activity against several bacteria. , Palmarumycin B 6 , with an LC 50 value of 32.7 μM against A. albopictus , is a member of the spirobisnaphthalene family that showed broad bioactivities, such as antifungal, antimicrobial, antitumor, anticancer, antiparasitic, anti-inflammatory, and cytotoxic activity. − Many reports related to the total synthesis, structure modification, and biological activity evaluation of the spirobisnaphthalene natural products have appeared in recent years. − The syntheses of palmarumycin CP 17 and its analogues were completed, and the bioassay results showed that they have antifungal activity against several phytopathogens . Because of the interesting larvicidal activity of palmarumycin B 6 against A. albopictus , its limited access in the fermentation extract of the endophytic fungus Berkleasmium sp., and the importance of the halogen atom in the A-ring, , the total synthesis and structure confirmation of palmarumycin B 6 were assessed in order to gain insight into the structure–activity relationships of spirobisnaphthalene compounds and explore their modes of action.…”